• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴 X 连锁低磷血症的成人生长骨骼肌肉特征:临床试验和调查数据分析。

Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data.

机构信息

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada.

出版信息

J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1249-e1262. doi: 10.1210/clinem/dgab739.

DOI:10.1210/clinem/dgab739
PMID:34636401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8852215/
Abstract

CONTEXT

Patients with X-linked hypophosphatemia (XLH) experience multiple musculoskeletal manifestations throughout adulthood.

OBJECTIVE

To describe the burden of musculoskeletal features and associated surgeries across the lifespan of adults with XLH.

METHODS

Three groups of adults were analyzed: subjects of a clinical trial, participants in an online survey, and a subgroup of the online survey participants considered comparable to the clinical trial subjects (according to Brief Pain Inventory worst pain scores of ≥ 4). In each group, the adults were categorized by age: 18-29, 30-39, 40-49, 50-59, and ≥ 60 years. Rates of 5 prespecified musculoskeletal features and associated surgeries were investigated across these age bands for the 3 groups.

RESULTS

Data from 336 adults were analyzed. In all 3 groups, 43% to 47% had a history of fracture, with the proportions increasing with age. The overall prevalence of osteoarthritis was > 50% in all 3 groups, with a rate of 23% to 37% in the 18- to 29-year-old group, and increasing with age. Similar patterns were observed for osteophytes and enthesopathy. Hip and knee arthroplasty was reported even in adults in their 30s. Spinal stenosis was present at a low prevalence, increasing with age. The proportion of adults with ≥ 2 musculoskeletal features was 59.1%, 55.0%, and 61.3% in the clinical trial group, survey group, and survey pain subgroup, respectively.

CONCLUSION

This analysis confirmed high rates of multiple musculoskeletal features beginning as early as age 20 years among adults with XLH and gradually accumulating with age.

摘要

背景

X 连锁低磷血症(XLH)患者在成年期会出现多种骨骼肌肉表现。

目的

描述 XLH 成人患者一生中骨骼肌肉特征和相关手术的负担。

方法

分析了三组成年人:临床试验的受试者、在线调查的参与者,以及在线调查参与者的一个亚组(根据简明疼痛量表最差疼痛评分≥4)被认为与临床试验受试者相当。在每个组中,成年人根据年龄分为 18-29 岁、30-39 岁、40-49 岁、50-59 岁和≥60 岁。调查了这三组在这些年龄组中 5 种特定骨骼肌肉特征和相关手术的发生率。

结果

对 336 名成年人的数据进行了分析。在所有三组中,有 43%至 47%的人有骨折史,且随着年龄的增长,这一比例也在增加。所有三组的骨关节炎总体患病率均>50%,18 至 29 岁组的患病率为 23%至 37%,且随着年龄的增长而增加。骨赘和肌腱病也出现了类似的模式。即使在 30 多岁的成年人中,也有髋关节和膝关节置换术的报告。脊柱狭窄的患病率较低,但随着年龄的增长而增加。在临床试验组、调查组和调查疼痛亚组中,有≥2 种骨骼肌肉特征的成年人比例分别为 59.1%、55.0%和 61.3%。

结论

这项分析证实,XLH 成年患者早在 20 岁时就出现了多种骨骼肌肉特征,并且随着年龄的增长逐渐积累。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/bd626163aa67/dgab739f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/dc514a606b28/dgab739f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/86241b0c9693/dgab739f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/e1bc5e9c94bc/dgab739f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/0605b8223d77/dgab739f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/ce9ed30794f6/dgab739f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/5abcbfc71259/dgab739f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/3be68e4b8a74/dgab739f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/608d17b710b6/dgab739f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/e1e4cecb8a09/dgab739f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/fb2e73887389/dgab739f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/bd626163aa67/dgab739f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/dc514a606b28/dgab739f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/86241b0c9693/dgab739f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/e1bc5e9c94bc/dgab739f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/0605b8223d77/dgab739f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/ce9ed30794f6/dgab739f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/5abcbfc71259/dgab739f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/3be68e4b8a74/dgab739f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/608d17b710b6/dgab739f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/e1e4cecb8a09/dgab739f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/fb2e73887389/dgab739f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7942/8852215/bd626163aa67/dgab739f0011.jpg

相似文献

1
Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data.伴 X 连锁低磷血症的成人生长骨骼肌肉特征:临床试验和调查数据分析。
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1249-e1262. doi: 10.1210/clinem/dgab739.
2
Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia.X 连锁低磷血症成人的骨关节炎、骨赘和肌腱末端病影响生物力学功能。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1798-814. doi: 10.1210/clinem/dgaa064.
3
Adult rheumatologic features, treatment and complications of X-linked hypophosphatemia.X 连锁低磷血症的成人风湿学特征、治疗和并发症。
Arch Pediatr. 2021 Oct;28(7):606-611. doi: 10.1016/j.arcped.2021.09.004. Epub 2021 Oct 6.
4
Incidence of Complications in 25 Adult Patients With X-linked Hypophosphatemia.25 例 X 连锁低磷血症成年患者的并发症发生率。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3682-e3692. doi: 10.1210/clinem/dgab282.
5
Development of Spinal Enthesopathies in Adults With X-linked Hypophosphatemia.成骨不全性佝偻病患者的脊柱末端病的发展。
J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1524-e1531. doi: 10.1210/clinem/dgad383.
6
Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms.成人性连锁低磷血症伴骨骼症状患者的生活质量受损。
Eur J Endocrinol. 2016 Mar;174(3):325-33. doi: 10.1530/EJE-15-0661.
7
Burden of disease of X-linked hypophosphatemia in Japanese and Korean patients: a cross-sectional survey.日本和韩国患者X连锁低磷血症的疾病负担:一项横断面调查。
Endocr J. 2022 Apr 28;69(4):373-383. doi: 10.1507/endocrj.EJ21-0386. Epub 2021 Nov 2.
8
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.一项评估抗 FGF23 抗体布罗索尤单抗在 X 连锁低磷血症成人患者中的疗效的随机、双盲、安慰剂对照、3 期临床试验:第 24 周主要分析。
J Bone Miner Res. 2018 Aug;33(8):1383-1393. doi: 10.1002/jbmr.3475. Epub 2018 Jun 26.
9
The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey.X连锁低磷血症的终身影响:疾病负担调查结果
J Endocr Soc. 2019 May 7;3(7):1321-1334. doi: 10.1210/js.2018-00365. eCollection 2019 Jul 1.
10
Lower limb bone geometry in adult individuals with X-linked hypophosphatemia: an observational study.伴 X 连锁低磷血症的成人下肢骨几何结构:一项观察性研究。
Osteoporos Int. 2022 Jul;33(7):1601-1611. doi: 10.1007/s00198-022-06385-z. Epub 2022 Apr 18.

引用本文的文献

1
Prevalence of enthesopathies in X-linked hypophosphatemia: an explorative ultrasound study.X连锁低磷血症中附着点病的患病率:一项探索性超声研究。
JBMR Plus. 2025 Jul 7;9(9):ziaf113. doi: 10.1093/jbmrpl/ziaf113. eCollection 2025 Sep.
2
Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan.关于X连锁低磷血症患者全生命周期管理与治疗的专家共识。
J Endocrinol Invest. 2025 Jul 1. doi: 10.1007/s40618-025-02611-7.
3
Real-world characteristics & disease history of patients with X-linked hypophosphatemia before treatment with burosumab.

本文引用的文献

1
Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia.X 连锁低磷血症成人的骨关节炎、骨赘和肌腱末端病影响生物力学功能。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1798-814. doi: 10.1210/clinem/dgaa064.
2
Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal.探讨 X 连锁低磷血症的负担:一项在技术评估过程中生成的患者陈述的机会性定性研究。
Adv Ther. 2020 Feb;37(2):770-784. doi: 10.1007/s12325-019-01193-0. Epub 2019 Dec 21.
3
Assessment on patient outcomes of primary hip replacement: an interrupted time series analysis from 'The National Joint Registry of England and Wales'.
布罗索尤单抗治疗前X连锁低磷血症患者的真实世界特征及疾病史
Arch Osteoporos. 2025 May 13;20(1):64. doi: 10.1007/s11657-025-01544-1.
4
Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults With X-Linked Hypophosphatemia.布罗索尤单抗与口服磷酸盐和活性维生素D治疗成人X连锁低磷血症的真实世界疗效比较
J Bone Miner Res. 2025 May 2. doi: 10.1093/jbmr/zjaf063.
5
The Diagnosis and Therapy of XLH.XLH的诊断与治疗。
Calcif Tissue Int. 2025 Apr 28;116(1):66. doi: 10.1007/s00223-025-01374-w.
6
A literature review of the healthcare resource use and productivity burden of X-linked hypophosphataemia.X连锁低磷血症的医疗资源利用和生产力负担的文献综述。
Front Health Serv. 2025 Apr 9;5:1285246. doi: 10.3389/frhs.2025.1285246. eCollection 2025.
7
Advancing patient evidence in XLH (APEX): rationale and design of a real-world XLH global data unification program.推进XLH患者证据(APEX):一项XLH真实世界全球数据统一计划的基本原理与设计
Front Endocrinol (Lausanne). 2025 Apr 7;16:1471127. doi: 10.3389/fendo.2025.1471127. eCollection 2025.
8
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline.成人X连锁低磷血症的管理:国际工作组临床实践指南
J Clin Endocrinol Metab. 2025 Jul 15;110(8):2353-2370. doi: 10.1210/clinem/dgaf170.
9
X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline.儿童X连锁低磷血症的管理:国际工作组临床实践指南
J Clin Endocrinol Metab. 2025 Feb 17. doi: 10.1210/clinem/dgaf093.
10
Understanding the structural biology of osteomalacia through multiscale 3D X-ray and electron tomographic imaging: a review of X-linked hypophosphatemia, the mouse model, and imaging methods.通过多尺度三维X射线和电子断层成像理解骨软化症的结构生物学:对X连锁低磷血症、小鼠模型及成像方法的综述
JBMR Plus. 2024 Dec 30;9(2):ziae176. doi: 10.1093/jbmrpl/ziae176. eCollection 2025 Feb.
原发性髋关节置换术患者结局评估:来自“英格兰和威尔士国家关节注册处”的中断时间序列分析。
BMJ Open. 2019 Nov 21;9(11):e031599. doi: 10.1136/bmjopen-2019-031599.
4
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial.布罗索尤单抗可改善 X 连锁低磷血症成人的佝偻病组织形态计量学指标:一项 3 期、单臂、国际试验。
J Bone Miner Res. 2019 Dec;34(12):2183-2191. doi: 10.1002/jbmr.3843. Epub 2019 Oct 1.
5
The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey.X连锁低磷血症的终身影响:疾病负担调查结果
J Endocr Soc. 2019 May 7;3(7):1321-1334. doi: 10.1210/js.2018-00365. eCollection 2019 Jul 1.
6
Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH).儿童和青少年 X 连锁低磷血症(XLH)的诊断、治疗监测和随访。
Metabolism. 2020 Feb;103S:153892. doi: 10.1016/j.metabol.2019.03.009. Epub 2019 Mar 27.
7
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.一项评估抗 FGF23 抗体布罗索尤单抗在 X 连锁低磷血症成人患者中的疗效的随机、双盲、安慰剂对照、3 期临床试验:第 24 周主要分析。
J Bone Miner Res. 2018 Aug;33(8):1383-1393. doi: 10.1002/jbmr.3475. Epub 2018 Jun 26.
8
Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations.X 连锁低磷血症成年患者的结局,由 PHEX 基因突变引起。
J Inherit Metab Dis. 2018 Sep;41(5):865-876. doi: 10.1007/s10545-018-0147-6. Epub 2018 Feb 19.
9
Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia.英国成骨不全症、X连锁低磷血症和骨纤维发育不良患者的健康相关生活质量及成本效用模拟
Orphanet J Rare Dis. 2016 Nov 28;11(1):160. doi: 10.1186/s13023-016-0538-4.
10
Indication criteria for total hip or knee arthroplasty in osteoarthritis: a state-of-the-science overview.骨关节炎全髋关节或全膝关节置换术的适应证标准:科学现状综述
BMC Musculoskelet Disord. 2016 Nov 9;17(1):463. doi: 10.1186/s12891-016-1325-z.